Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-09-25
2007-09-25
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S231200, C514S252140, C514S315000, C514S356000, C514S408000, C544S106000, C544S123000, C546S329000, C548S400000, C549S083000, C549S451000
Reexamination Certificate
active
10494077
ABSTRACT:
Described herein are compounds of formula (I) useful as antagonists of tachykinins in general, and in particular of neurokinin A; and the pharmaceutical formulations comprising the compounds of formula (I)
REFERENCES:
patent: 5610176 (1997-03-01), Horwell et al.
patent: 5780467 (1998-07-01), Dorn et al.
patent: 6262069 (2001-07-01), Liebeschuetz et al.
patent: 6294547 (2001-09-01), Oka et al.
patent: 6740682 (2004-05-01), Liebeschuetz
patent: 6855715 (2005-02-01), Liebeschuetz et al.
patent: 6878725 (2005-04-01), Liebeschuetz et al.
patent: 6900196 (2005-05-01), Liebeschuetz et al.
patent: 0 394 989 (1990-10-01), None
patent: WO94/04494 (1994-03-01), None
patent: WO 05/19966 (1995-07-01), None
patent: WO98/34949 (1998-08-01), None
patent: WO98/45262 (1998-10-01), None
patent: WO 00/14109 (2000-03-01), None
patent: WO 01/29066 (2001-04-01), None
International Search Report for International Application No. PCT/EP02/12022 completed Jul. 17, 2003.
D. Regoli, E. Escher, J. Mizrahi, Substance P—Structure-Activity Studies and the Development of Antagonists, Pharmacology 28: 301-320, 1984.
XP 000575827, Boden et al., Use of Dipeptide Chemical Library in the Development of Non-Peptide Tachykinin Nk3 Receptor Selective Antagonists, J. Med. Chem. 39, pp. 1664-1675, 1996.
XP 0008004494, Boyle et al., Rational Design of High Affinity Tachykinin NK2 Receptor Antagonists, Bioorganic & Medicinal Chemistry, vol. 2, No. 2, pp. 101-113, 1994.
XP 000917251, Boyle et al., Rational Sesign of High Affinity Tachykinin NK1 Receptor Antagonists, Bioorganic & Medicinal Chemistry, vol. 2, No. 5, pp. 357-370, 1994.
Altamura Maria
Caciagli Valerio
Fedi Valentina
Giannotti Danilo
Giolitti Alessandro
Chung Susannah L.
Lorusso & Associates
Menarini Ricerche S.P.A.
LandOfFree
Linear basic compounds having NK-2 antagonist activity and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Linear basic compounds having NK-2 antagonist activity and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Linear basic compounds having NK-2 antagonist activity and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3796989